Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose

No abstract is available for this paper.

• Publication year

  1993

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  1993-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF03188796PMID 8243504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses

  2010cited by this paper
• Pharmacokinetics of diltiazem and other calcium entry blockers.

  2009cited by this paper
• Haemodynamic and electrophysiologic effects of diltiazem.

  2009cited by this paper
• Synthesis, characterization, and Ca2+ antagonistic activity of diltiazem metabolites.

  1992cited by this paper
• Stability of Diltiazem and Its Metabolites in Plasma During Storage

  1991cited by this paper
• Effect of Diltiazem and its Metabolites on the Uptake of Adenosine in Blood: an In‐vitro Investigation *

  1991cited by this paper
• No Effect of Terodiline on Anticoagulation Effect of Warfarin and Steady‐State Plasma Levels of Warfarin Enantiomers in Healthy Volunteers

  1989cited by this paper
• Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers.

  1989cited by this paper
• High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers.

  1989cited by this paper
• The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose

  1989cited by this paper
• Pharmacokinetics of diltiazem in patients with unstable angina pectoris

  1988cited by this paper
• Metabolism of diltiazem. I. Structures of new acidic and basic metabolites in rat, dog and man.

  1988cited by this paper
• Calcium Channel Receptor Binding Studies for Diltiazem and Its Major Metabolites: Functional Correlation to Inhibition of Portal Vein Myogenic Activity

  1987cited by this paper
• Liquid chromatographic determination of diltiazem and its metabolites using trans isomers as internal standards, with dynamic modification of the solid phase by addition of an amine to the mobile phase.

  1987cited by this paper
• N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives.

  1987cited by this paper
• The role of calcium channel blockers in the treatment of hypertension.

  1986cited by this paper
• CALCIUM ANTAGONISM—WITH SPECIAL REFERENCE TO DILTIAZEM

  1986cited by this paper
• High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics.

  1985cited by this paper
• Cardiovascular Effects of the Metabolites of Diltiazem in Dogs

  1985cited by this paper
• Studies on the metabolism of diltiazem in man.

  1984cited by this paper
• Inhibition of Platelet Aggregation by Diltiazem: Comparison with Verapamil and Nifedipine and Inhibitory Potencies of Diltiazem Metabolites

  1983cited by this paper
• Pharmacokinetic and pharmacodynamic effects of diltiazem.

  1983cited by this paper
• The Pharmacokinetics and Pharmacology of Oral Diltiazem in Normal Volunteers

  1981cited by this paper
• Metabolic fate of d-cis-3-acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride (CRD-401).

  1971cited by this paper

• Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals

  2023cites this paper
• Drug Repurposing: In Silico Modeling of Streptococcus Infection

  2021cites this paper
• Metabolic N-Dealkylation and N-Oxidation as Elucidators of the Role of Alkylamino Moieties in Drugs Acting at Various Receptors

  2021cites this paper
• International Journal of Scientific Research in Science and Technology

  2021cites this paper
• Contribution of Gut Microbiome to Human Health and the Metabolism or Toxicity of Drugs and Natural Products

  2020cites this paper
• Mapping human microbiome drug metabolism by gut bacteria and their genes

  2019cites this paper
• Contribution of Metabolites to P 450 Inhibition – Based Drug – Drug Interactions : Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group s

  2015cites this paper
• Contribution of Metabolites to P450 Inhibition–Based Drug–Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group

  2015cites this paper
• Preparation and in vitro evaluation of a polymer based controlled release dry powder inhaler formulation for pulmonary delivery

  2014cites this paper
• Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women

  2014influential citation
• Repeated dosing of piperine induced gene expression of P‐glycoprotein via stimulated pregnane‐X‐receptor activity and altered pharmacokinetics of diltiazem in rats

  2012cites this paper
• Effects of Ticlopidine on the Pharmacokinetics of Diltiazem and Its Main Metabolite, Desacetyldiltiazem, in Rats

  2011cites this paper
• Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin

  2011cites this paper
• Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P‐glycoprotein inhibition by lovastatin

  2011cites this paper
• Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam.

  2010cites this paper
• Semiphysiologically Based Pharmacokinetic Models for the Inhibition of Midazolam Clearance by Diltiazem and Its Major Metabolite

  2009cites this paper
• Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats

  2009cites this paper
• effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats

  2007cites this paper
• [Drug interaction of fluvoxamine, a selective serotonin reuptake inhibitor].

  2006cites this paper
• Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats.

  2005cites this paper
• Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: Focus on dosing regimen, dosage form, and formulation

  2005cites this paper
• High-performance liquid chromatography-mass spectrometry analysis of diltiazem and 11 of its phase I metabolites in human plasma.

  2003cites this paper
• Penetration of diltiazem into breast milk and its pharmacokinetics in the lactating rabbit

  2002cites this paper
• Sex‐related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P‐glycoprotein

  2002cites this paper
• Pharmacokinetic Interaction Between Tacrolimus and Diltiazem

  2002cites this paper
• Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype

  2002cites this paper
• Effect of Administration Route and Length of Exposure on Pharmacokinetics and Metabolism of Diltiazem in Dogs

  2001cites this paper
• CYP2D6 is involved in O-demethylation of diltiazem

  2000cites this paper
• Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels

  2000cites this paper
• A simple and sensitive high-performance liquid chromatography assay of diltiazem and main metabolites in renal transplanted patients.

  1999cites this paper
• Stability of diltiazem in whole blood: forensic implications.

  1998cites this paper
• Diltiazem disposition and metabolism in recipients of renal transplants.

  1998cites this paper
• Pharmacokinetics and Haemodynamic Effect of Diltiazem in Rats: Effect of Route of Administration

  1998cites this paper
• Effects of age, gender, and diurnal variation on the steady‐state pharmacokinetics of BMS‐181101, an antidepressant, in healthy subjects

  1997cites this paper
• Effect of Phenobarbital Pretreatment on the Pharmacokinetics and Metabolism of Diltiazem in Rats

  1996cites this paper
• Steady-state plasma concentrations of diltiazem and its metabolites in patients and healthy volunteers.

  1996cites this paper
• Gender Differences in Exercise and Recovery Blood Pressure Responses in Normal Volunteers Given Diltiazem

  1995cites this paper
• Endogenous natriuretic factors 3: isolation and characterization of human natriuretic factors LLU-alpha, LLU-beta 1, and LLU-gamma.

  1995cites this paper
• Use of Parent Drug and Metabolite Data in Bioavailability Assessment of a Novel Diltiazem HC1 Once-Daily Product

  1995cites this paper
• [Women in clinical trials].

  1995cites this paper
• The effect of multiple doses of ranitidine on the pharmacokinetics and metabolism of diltiazem in dogs

  1994cites this paper
• Pharmacokinetics and metabolism of diltiazem in rats following a single intra-arterial or single oral dose

  1994cites this paper